Case studyFortune 100: 80% less compliance workRead the Story
RiskWatch
Updated May 15, 2026 · 10 platforms evaluated

Top 10 Compliance Management Software for Medical Devices in 2026: A Buyer-First Comparison

Honest 2026 ranking of the 10 best medical device compliance platforms for FDA QMSR (21 CFR Part 820), EU MDR, IVDR, ISO 13485, ISO 14971, UDI, and 510(k).

By RiskWatch Editorial · Medical Device Risk and Compliance Software Research

Verdict

TL;DR

If you run quality, regulatory affairs, or product development at a medical device manufacturer or in vitro diagnostic company in 2026 and you want one platform that covers the FDA Quality Management System Regulation (21 CFR Part 820 QMSR, effective February 2 2026 and now harmonised with ISO 13485:2016), EU Medical Device Regulation 2017/745 with the Regulation 2024/1860 legacy-device transition deadlines, EU IVDR 2017/746 with its parallel transition timeline, ISO 14971 risk management, IEC 62304 software-of-medical-device lifecycle, UDI under 21 CFR Part 830 and EUDAMED, 510(k) and De Novo and PMA submission workflow, MDSAP audit coverage, and post-market surveillance plus vigilance reporting, the shortlist narrows fast. RiskWatch ranks first on our weighted score because its 40+ framework library carries pre-mapped QMSR plus ISO 13485 plus ISO 14971 plus EU MDR plus IVDR plus IEC 62304 plus UDI plus 21 CFR Part 11 controls in one tenant with single-tenant deployment for validated environments. Greenlight Guru is the default for a MedTech-first quality team that wants the deepest design-controls and 510(k) submission workflow built around 21 CFR Part 820 and ISO 13485 from day one. MasterControl fits commercial-stage device manufacturers running large training, document, and batch-record programmes alongside a CAPA workflow. Veeva Vault QualityOne fits device companies already running Vault RIM or Vault Clinical. ETQ Reliance fits global manufacturers running site-by-site validated rollouts. Sparta TrackWise Digital fits large manufacturers migrating from legacy on-prem TrackWise. ComplianceQuest fits Salesforce shops. Qualio fits emerging device startups under series C. Pilgrim Quality Solutions fits IQVIA-aligned mid-market manufacturers. AssurX fits combination-products and electromedical manufacturers that need a configurable eQMS. Pick by where your design history file lives and whether the platform will survive an FDA Form 483, an EU Notified Body audit, or an MDSAP inspection, not by analyst-quadrant placement.

Pick by use case

Where each platform fits

Multi-framework medical device manufacturer running FDA QMSR + ISO 13485 + EU MDR + IVDR + ISO 14971 + UDI
RiskWatch: 40+ pre-mapped framework libraries including FDA 21 CFR Part 820 QMSR (effective Feb 2 2026) + ISO 13485 + ISO 14971 + IEC 62304 + EU MDR + IVDR + UDI + 21 CFR Part 11 in one tenant; single-tenant deployment for validated environments.
MedTech-first quality team wanting the deepest 510(k) + design-controls workflow
Greenlight Guru: Purpose-built around 21 CFR Part 820 design controls and ISO 13485; native 510(k) + De Novo + PMA submission templates plus EU MDR technical-file workflow; G2 Leader with 1,000+ reviews.
Commercial-stage device manufacturer running batch records, training, and CAPA at scale
MasterControl: Used by the US FDA itself for internal quality processes; deepest installed base in regulated manufacturing for document control, training, and CAPA; Manufacturing Excellence adds electronic device history records (eDHR).
Device manufacturer already running Veeva Vault RIM, Clinical, or Submissions
Veeva Vault QualityOne: Cloud QMS sharing the Vault data model and validated infrastructure with Vault RIM, Vault Submissions, and Vault Clinical; natural pick for combination-product manufacturers running both drug and device workstreams on Vault.
Global device manufacturer running site-by-site validated QMS rollouts
ETQ Reliance: Hexagon-owned since January 2022; 40+ pre-built compliance applications; Reliance NXG architecture supports site-by-site validated rollout with delta-revalidation rather than full re-validation on platform updates.
Large device manufacturer migrating from legacy on-prem TrackWise
Sparta TrackWise Digital: Honeywell-owned since January 2021; legacy TrackWise installed at 9 of the top 10 global pharma and many of the top device manufacturers; AWS-hosted cloud successor with native validation.
Salesforce-anchored device or combination-product manufacturer
ComplianceQuest: Salesforce-native EQMS + EHS + PLM with 100% cloud architecture; native Salesforce SSO, AppExchange, and Einstein AI; multi-tenant SaaS with validated configuration.
Emerging device startup under series C running first 510(k)
Qualio: Cloud-native multi-tenant QMS at $24K-$50K published entry; targeted at virtual device startups, contract manufacturers, and clinical-stage IVD shops under 250 staff; fastest first-510(k)-submission readiness.
Mid-market manufacturer needing IQVIA-aligned validated QMS
Pilgrim Quality Solutions: IQVIA-owned since 2015; SmartSolve EQMS plus iComplyGRC for supplier and compliance risk; deep medical-device + life-sciences pedigree across 800+ customers.
Combination-products or electromedical manufacturer wanting configurable eQMS
AssurX: Configurable eQMS with 30+ years in regulated electronics and medical devices; deep CAPA, supplier quality, audit, complaint, and submission management; AssurX FDA UDI module for 21 CFR Part 830 and EUDAMED.

Medical device compliance is not one buying category. A virtual device startup running its first 510(k) needs a cloud QMS that can stand up validated SOP control and design history file (DHF) workflow inside 60 days for under $50K. A top-20 global device manufacturer needs a validated enterprise platform that handles complaint handling, CAPA, supplier quality, training, and device history record (DHR) workflow across 30+ sites with site-by-site validation packages and an FDA-grade audit trail. A combination-product manufacturer needs a system that handles 21 CFR Part 820 QMSR design controls alongside 21 CFR Part 211 GMP and 21 CFR Part 11 electronic records, in one tenant. An in vitro diagnostic developer needs IVDR 2017/746 technical-file workflow alongside FDA submission templates for 510(k), De Novo, and PMA. The ten platforms in this ranking each solve part of that brief; none solves all of it equally well.

We considered 22 platforms across G2's Quality Management QMS and Life Sciences Compliance categories, the Capterra Medical Device Software shortlist, Gartner's QMS Hype Cycle, and the AdvaMed and MedTech Europe vendor catalogues. We cut to ten by removing pure document-management tools without an embedded device-quality engine (Box, M-Files outside their device-specific shape), excluding ERP-led quality modules whose validated lifecycle is sold as a customisation (SAP QM, Oracle Agile PLM Quality), dropping pure trust-management platforms that do not address ISO 13485 or QMSR (Vanta, Drata, Secureframe in their generic SOC 2 shape), and excluding general GRC tools without a medical-device QMS data model (AuditBoard / Optro, Workiva, Intelex). The result is ten platforms a quality, regulatory affairs, or product-development leader at a device manufacturer or IVD company might shortlist in 2026.

Pricing transparency in medical device compliance is worse than in adjacent categories. Eight of the ten platforms here will not publish a list price, and the two that do (Qualio and Greenlight Guru) publish only entry-tier ranges. That is a category problem driven by site-by-site validation variance, not a competitive moat. We have triangulated prices for the opaque vendors from two or more independent third-party sources (Vendr, SoftwareAdvice, SelectHub, SmartSuite) and dated each estimate. Device-specific evaluation criteria layered on top of the default methodology: FDA 21 CFR Part 820 QMSR coverage at the sub-section level (Subpart B design controls, Subpart C document controls, Subpart H acceptance activities, Subpart M records, Subpart O servicing) with the February 2 2026 effective date for the ISO 13485:2016 harmonisation, ISO 14971 risk-management file workflow, IEC 62304 software-of-medical-device lifecycle support, EU MDR 2017/745 technical-file workflow with the Regulation 2024/1860 legacy transition deadlines (December 31 2027 for class III, December 31 2028 for class IIb, December 31 2029 for class IIa / Im / Is), EU IVDR 2017/746 transition deadlines on the same Regulation 2024/1860 schedule, UDI assignment and submission to FDA GUDID and EUDAMED, 510(k) / De Novo / PMA submission lifecycle, MDSAP audit readiness across the five participating regulators (FDA, Health Canada, ANVISA, TGA, MHLW / PMDA), and post-market surveillance plus vigilance reporting under MDR Article 87 and FDA 21 CFR 803.

At-a-glance

Comparison table

The 10 platforms scored on the methodology weights at the bottom of this page. Pricing-transparency pill is the buyer-honesty signal.

RankProductBest forPricing transparencyG2Verdict
1RiskWatch
RiskWatch International
Mid-market and large device manufacturers running 3+ frameworks (FDA QMSR + ISO 13485 + EU MDR + IVDR + ISO 14971 + IEC 62304 + 21 CFR Part 11 + IT compliance such as SOC 2 or HIPAA) who want one tenant for compliance, supplier risk, and IT security assessment with customer-owned data residency.Partial4.5/5
60+ reviews
Pre-built FDA 21 CFR Part 820 QMSR control library mapped to Subpart B (Design...
2Greenlight Guru
Greenlight Guru, Inc.
Medical device manufacturers and IVD companies of any size running a MedTech-first quality programme aligned to 21 CFR Part 820 QMSR, ISO 13485, ISO 14971, IEC 62304, and the EU MDR / IVDR technical-file workflow, especially those preparing for or maintaining 510(k), De Novo, or PMA submissions.Partial4.6/5
1050+ reviews
Purpose-built medical device eQMS organised around 21 CFR Part 820 design controls;...
3MasterControl
MasterControl, Inc.
Commercial-stage medical device manufacturers, contract manufacturers, and combination-product manufacturers that want a single validated EQMS owning document control, training, CAPA, change control, device history records, and supplier quality end-to-end with FDA-grade audit-trail credibility.Opaque4.3/5
540+ reviews
US Food and Drug Administration uses MasterControl for internal document and quality...
4Veeva Vault QualityOne
Veeva Systems Inc.
Medical device and combination-product manufacturers already running two or more Veeva Vault applications (RIM, Submissions, Clinical) that want a QMS sharing the same validated data model and three-release-per-year cadence.Opaque4.2/5
180+ reviews
Native interoperability with Vault RIM, Vault Submissions, and Vault Clinical on the...
5ETQ Reliance
ETQ (Hexagon AB subsidiary)
Large and global medical device manufacturers running site-by-site validated rollouts who need a configurable enterprise QMS, deep supplier quality across many manufacturing sites, and an integration story with Hexagon Manufacturing Intelligence or Smart Manufacturing.Opaque4.4/5
220+ reviews
Gartner Magic Quadrant QMS Leader (2024 placement); strong analyst credibility for...
6Sparta TrackWise Digital
Sparta Systems (Honeywell company)
Top-20 global device manufacturers, large combination-product manufacturers, and contract manufacturers running cloud-first quality strategies, especially those migrating from legacy on-prem TrackWise or already running Honeywell Forge / Experion across manufacturing sites.Opaque4.2/5
110+ reviews
Legacy TrackWise is installed at many of the top medical-device manufacturers per...
7ComplianceQuest
ComplianceQuest, Inc.
Mid-market and growing medical device manufacturers, IVD developers, and combination-product companies already running Salesforce Sales Cloud, Service Cloud, or Marketing Cloud who want a cloud-native EQMS that shares the same data platform.Opaque4.5/5
240+ reviews
Salesforce-native architecture means inherited Salesforce SSO, mobile, AppExchange,...
8Qualio
Qualio, Inc.
Emerging medical device startups, IVD developers, contract manufacturers, and clinical-stage device companies under 250 staff that need a validated cloud QMS in under 90 days with published pricing.Partial4.6/5
400+ reviews
Published entry pricing ($24K Essentials, $50K Plus); the most transparent QMS pricing...
9Pilgrim Quality Solutions
Pilgrim Quality Solutions (an IQVIA business)
Mid-market medical device manufacturers and IVD developers that want an IQVIA-aligned vendor relationship and a 30-year regulated-life-sciences pedigree in their QMS supplier.Opaque4.1/5
130+ reviews
30-year operating history with regulated life-sciences customers; 800+ customer...
10AssurX
AssurX, Inc.
Combination-product manufacturers, electromedical equipment makers, and mid-market device manufacturers that want a configurable eQMS with native 510(k) / PMA / EU MDR / IVDR submission management and UDI module support.Opaque4.2/5
110+ reviews
30-year operating history in regulated electronics and medical devices; deep customer...
Calculator

Estimate the licence cost

Drag the slider to your headcount. Estimates use each vendor's published or triangulated tiers. Opaque vendors show Contact sales.

500
11.3k2.5k3.8k5k
RiskWatch
Professional (≤ 1,000 employees)
$36,000/yr
Greenlight Guru
Pro (quote-only tier)
Contact sales
MasterControl
Mid-market (est.) (quote-only tier)
Contact sales
Veeva Vault QualityOne
Clinical-stage (est.) (quote-only tier)
Contact sales
ETQ Reliance
Mid-market (est.) (quote-only tier)
Contact sales
Sparta TrackWise Digital
Mid-market (est.) (quote-only tier)
Contact sales
ComplianceQuest
Mid-market (est.) (quote-only tier)
Contact sales
Qualio
Enterprise (quote-only tier)
Contact sales
Pilgrim Quality Solutions
Mid-market (est.) (quote-only tier)
Contact sales
AssurX
Mid-market (est.) (quote-only tier)
Contact sales

Estimates only. Opaque-pricing vendors do not publish list prices; bands are triangulated from public third-party sources dated 2026-05-15. Implementation services, module add-ons, and renewal escalators are extra.

Pick your own weights

Decision matrix

Default weights match the methodology at the bottom of this page. Drag the sliders to match your priorities and re-rank in real time.

20%

How quickly a non-technical control owner reaches first value

20%

Module coverage across ERM, IT, audit, TPRM, BC

20%

Price to value ratio at mid-market

15%

Quality and responsiveness of vendor support

15%

Handling 5,000+ employees, multiple entities, regions

10%

Breadth of native connectors and APIs

Weights sum: 100%
  1. 1
    Greenlight Guru
    Editorial rank #2
    8.73
  2. 2
    RiskWatch
    Editorial rank #1
    8.64
  3. 3
    Qualio
    Editorial rank #8
    8.53
  4. 4
    MasterControl
    Editorial rank #3
    8.48
  5. 5
    ComplianceQuest
    Editorial rank #7
    8.46
  6. 6
    Veeva Vault QualityOne
    Editorial rank #4
    8.35
  7. 7
    ETQ Reliance
    Editorial rank #5
    8.29
  8. 8
    Sparta TrackWise Digital
    Editorial rank #6
    8.19
  9. 9
    Pilgrim Quality Solutions
    Editorial rank #9
    7.93
  10. 10
    AssurX
    Editorial rank #10
    7.89
Switching cost

Migration matrix

Read row-to-column. Row = today's platform, column = tomorrow's. Colour reflects realistic switching effort, not vendor sales pitches.

From / To
RiskWatch
Greenlight Guru
MasterControl
Veeva Vault QualityOne
ETQ Reliance
Sparta TrackWise Digital
ComplianceQuest
Qualio
Pilgrim Quality Solutions
AssurX
RiskWatch.EMEMMEEMM
Greenlight GuruE.MMMHEEHH
MasterControlEE.EEEEEMM
Veeva Vault QualityOneEEE.EMEEMM
ETQ RelianceEEEE.EEEEE
Sparta TrackWise DigitalEEEEE.EEEE
ComplianceQuestEEMEMM.EMM
QualioMMHMHHM.HH
Pilgrim Quality SolutionsEEEEEEEE.E
AssurXEEEEEEEEE.
Easy (E)Moderate (M)Hard (H)Source: per-vendor migration field with radar-profile fallback. Treat as a directional guide, not a quote.
Methodology

How we scored and why you should trust it

The methodology is the only thing keeping this page honest. Read it carefully and apply your own weights in the decision matrix above.

We scored each of the ten platforms on six axes: Ease of Use (20%), Feature Breadth (20%), Value (20%), Customer Support (15%), Scalability (15%), and Integrations (10%). Scores are 0-10 and calibrated within this medical-device-specific category (highest features 9.5, lowest 6.5). Ratings reference G2 and Capterra figures pulled 2026-05-15. Pricing reflects the most-recent published or triangulated figures, also pulled 2026-05-15; where pricing is opaque we report a range based on two or more public third-party sources. Device-specific evaluation criteria layered on top: FDA 21 CFR Part 820 QMSR sub-section coverage (Subpart B Design Controls § 820.30 / Subpart C Document Controls § 820.40 / Subpart E Purchasing Controls § 820.50 / Subpart G Production and Process Controls § 820.70 / Subpart H Acceptance Activities § 820.80 / Subpart I Nonconforming Product § 820.90 / Subpart J Corrective and Preventive Action § 820.100 / Subpart M Records § 820.180 / Subpart O Servicing § 820.200) with the February 2 2026 effective date for the ISO 13485:2016 harmonisation under 89 FR 7496; ISO 13485:2016 clause-level alignment; ISO 14971:2019 risk-management file workflow; IEC 62304 software-of-medical-device lifecycle support; EU MDR 2017/745 technical-file workflow with Regulation 2024/1860 legacy transition deadlines (Dec 31 2027 / 2028 / 2029 by risk class); EU IVDR 2017/746 transition deadlines; UDI assignment for FDA GUDID and EUDAMED; 510(k) / De Novo / PMA submission lifecycle; MDSAP audit readiness; post-market surveillance and vigilance reporting under MDR Article 87 and FDA 21 CFR 803; 21 CFR Part 11 electronic records and signatures; FDA Computer Software Assurance (CSA) draft guidance (September 2022). We re-verify this page quarterly.

Weights used in the editorial ranking

Ease of use
20%
Feature breadth
20%
Value
20%
Customer support
15%
Scalability
15%
Integrations
10%
#1

RiskWatch

RiskWatch International · Founded 1993 · Annapolis, MD, USA

Multi-framework medical-device compliance platform with QMSR, ISO 13485, ISO 14971, EU MDR, IVDR, IEC 62304, and UDI in one tenant.

Partial pricingG2 4.5 · Capterra 4.6 · 60+ reviews

Summary

RiskWatch ships a medical device compliance assessment platform built around pre-mapped control libraries for FDA 21 CFR Part 820 QMSR (effective Feb 2 2026 and harmonised with ISO 13485:2016), ISO 13485, ISO 14971, IEC 62304, EU MDR 2017/745, EU IVDR 2017/746, UDI under 21 CFR Part 830, 21 CFR Part 11 electronic records and signatures, and 35+ additional frameworks including ISO 27001, SOC 2, NIST 800-53, and HIPAA. The platform runs on a survey-based assessment engine, an evidence vault with versioning, a supplier and contract-manufacturer risk module, and a cross-mapping engine that auto-detects shared controls across QMSR and ISO 13485 and EU MDR. Customers include US federal healthcare programmes, regional health systems, and life-sciences customers running combined IT plus quality compliance briefs. Single-tenant deployment lets device legal and IT keep customer-owned data residency for validated environments where the design history file and device history record must remain on customer-controlled infrastructure.

Strengths
  • Pre-built FDA 21 CFR Part 820 QMSR control library mapped to Subpart B (Design Controls § 820.30) through Subpart O (Servicing § 820.200) out of the box, current with the 89 FR 7496 Feb 2 2026 effective date
  • ISO 13485:2016 clause-level mapping in the same tenant as QMSR; cross-mapping engine auto-detects shared controls across QMSR + ISO 13485 + EU MDR + IVDR
  • ISO 14971:2019 risk-management file workflow and IEC 62304 software-of-medical-device lifecycle library shipped with the platform
  • EU MDR 2017/745 + IVDR 2017/746 framework libraries kept current with the Regulation 2024/1860 legacy transition deadlines (Dec 31 2027 / 2028 / 2029 by risk class)
  • 33-year operating history with regulated US federal customers (VA, Medicaid agencies) and life-sciences buyers running combined IT plus quality compliance briefs
  • Single-tenant deployment with customer-owned data residency for validated environments; useful when QA and IT will not approve multi-tenant SaaS for the design history file or device history record
  • Supplier and contract-manufacturer risk module supports ISO 13485 § 7.4 purchasing-controls and the EU MDR Article 10(9) supplier-management angle in one workspace
  • Survey-based assessment engine works for non-technical QA owners (validation leads, regulatory affairs specialists) without SQL or workflow-builder skills
Weaknesses
  • Not a validated electronic QMS in the Greenlight Guru, MasterControl, or Veeva Vault QualityOne sense; does not ship native design history file (DHF), device history record (DHR), or device master record (DMR) modules out of the box
  • No native 510(k) / De Novo / PMA submission templates; pair with Greenlight Guru, Veeva Vault, or a regulatory submission specialist for the submission workflow
  • Public pricing remains partially opaque; we publish typical contract bands but the public site still routes buyers through a quote workflow
  • Brand awareness on G2 / Capterra in medical-device quality specifically is lower than Greenlight Guru or MasterControl; total third-party review volume sits below 100
  • No native validation lifecycle service (URS, FS, DS, IQ, OQ, PQ) the way MasterControl Validation Excellence Tool ships out of the box; configuration of validated environments requires partner support
  • UI shows operational-heritage in places; newer entrants (ComplianceQuest, Qualio) have a more polished first-run experience for SaaS-style device startup buyers
Best for

Mid-market and large device manufacturers running 3+ frameworks (FDA QMSR + ISO 13485 + EU MDR + IVDR + ISO 14971 + IEC 62304 + 21 CFR Part 11 + IT compliance such as SOC 2 or HIPAA) who want one tenant for compliance, supplier risk, and IT security assessment with customer-owned data residency.

Worst for

Pre-revenue device startups shopping for a single validated EQMS to own design history file, device history record, and 510(k) submission workflow end-to-end; Greenlight Guru, MasterControl, or Qualio fit that brief better.

Key features

  • Pre-built FDA 21 CFR Part 820 QMSR library (Subpart B Design Controls / Subpart C Document Controls / Subpart E Purchasing Controls / Subpart G Production and Process Controls / Subpart H Acceptance Activities / Subpart I Nonconforming Product / Subpart J CAPA / Subpart M Records / Subpart O Servicing)
  • ISO 13485:2016 clause-level control library with QMSR cross-mapping
  • ISO 14971:2019 risk-management file workflow
  • IEC 62304 software-of-medical-device lifecycle library
  • EU MDR 2017/745 + IVDR 2017/746 technical-file workflow with Regulation 2024/1860 transition tracking
  • UDI assignment library for FDA GUDID and EUDAMED
  • 21 CFR Part 11 electronic records and signatures library cross-mapped to QMSR § 820.180
  • Supplier and contract-manufacturer risk register with ISO 13485 § 7.4 purchasing-controls workflow

Integrations

25+ native. Notable: Microsoft Entra ID (SAML SSO), Okta, Microsoft 365 / SharePoint, Slack, Jira, Salesforce, Custom REST API.

Target size

100 to 25,000 employees · US · Canada · EU · UK · AU

#2

Greenlight Guru

Greenlight Guru, Inc. · Founded 2013 · Indianapolis, IN, USA

MedTech-first eQMS purpose-built for 21 CFR Part 820 design controls plus ISO 13485 plus EU MDR plus IVDR.

Partial pricingG2 4.6 · Capterra 4.7 · 1050+ reviews

Summary

Greenlight Guru was founded in 2013 in Indianapolis by David DeRam, Jon Speer, and Chad Riddle as a purpose-built medical-device eQMS rather than a generic life-sciences QMS retrofitted for devices. The product is organised around the 21 CFR Part 820 design controls workflow with native design history file (DHF), device master record (DMR), and risk-management file structures. JMI Equity led a growth investment in 2021. Greenlight Guru is a G2 Leader in the Quality Management QMS category with 1,000+ verified reviews; the platform serves 1,000+ device manufacturers and IVD companies. Coverage spans design controls, document control, training, CAPA, audit, supplier quality, complaint handling, post-market surveillance, and submission management for 510(k), De Novo, PMA, EU MDR technical files, and IVDR.

Strengths
  • Purpose-built medical device eQMS organised around 21 CFR Part 820 design controls; native DHF, DMR, and risk-management file data structures from day one
  • Deepest 510(k) / De Novo / PMA submission workflow in the category with pre-built templates aligned to FDA eSTAR and the 89 FR 7496 Feb 2 2026 QMSR harmonisation
  • Native EU MDR 2017/745 and EU IVDR 2017/746 technical-file workflow kept current with Regulation 2024/1860 legacy transition deadlines
  • G2 Leader for Quality Management QMS with 1,000+ verified reviews and high satisfaction patterns from MedTech reviewers
  • Indianapolis headquarters with a deep medical-device customer reference base; True Quality podcast and community programme support MedTech-specific buyer journeys
  • ISO 13485:2016 clause-level workflow with ISO 14971:2019 risk-management file integration; IEC 62304 software lifecycle support for software-of-medical-device buyers
Weaknesses
  • Pricing is partial-public; SoftwareAdvice and SelectHub triangulate $25K-$40K/yr Essentials and $60K-$120K/yr Pro for mid-market and growing manufacturers
  • JMI Equity ownership since 2021 raises typical PE renewal-uplift risk; reviewers report 8-12% annual uplifts at renewal
  • Configurable workflow beyond MedTech defaults can require professional services; non-standard combination-product workflows (drug-eluting devices, drug-device combos) need scoped engagement
  • Native batch-record (electronic device history record) depth is competitive at mid-market scale but trails MasterControl Manufacturing Excellence for high-volume manufacturers running multi-shift production
  • Smaller integration count than ServiceNow, Riskonnect-style platforms, or Veeva Vault QualityOne for buyers running complex ERP / MES adjacencies
  • Less natural fit for non-device life-sciences workstreams (pure pharma GMP, pure clinical research) at a combination-product manufacturer running both drug and device sides
Best for

Medical device manufacturers and IVD companies of any size running a MedTech-first quality programme aligned to 21 CFR Part 820 QMSR, ISO 13485, ISO 14971, IEC 62304, and the EU MDR / IVDR technical-file workflow, especially those preparing for or maintaining 510(k), De Novo, or PMA submissions.

Worst for

Pure pharmaceutical manufacturers without a device pipeline; the platform is device-first by design and the GMP-led quality workflow is thinner than MasterControl or Veeva Vault QMS for that brief.

Key features

  • Design history file (DHF) with native 21 CFR Part 820 § 820.30 design controls workflow
  • Device master record (DMR) and device history record (DHR) structures
  • ISO 14971:2019 risk-management file with hazard analysis and risk matrix
  • IEC 62304 software-of-medical-device lifecycle workflow
  • 510(k) / De Novo / PMA submission templates aligned to FDA eSTAR
  • EU MDR + IVDR technical-file workflow with Regulation 2024/1860 transition tracking
  • CAPA workflow with effectiveness checks
  • Supplier quality with ISO 13485 § 7.4 audit tracking
  • Post-market surveillance and complaint handling with FDA 21 CFR 803 and MDR Article 87 alignment

Integrations

35+ native. Notable: Microsoft Entra ID (SAML SSO), Okta, Jira, Slack, DocuSign, Microsoft 365, Native REST API.

Target size

10 to 5,000 employees · US · Canada · EU · UK · AU · APAC

#3

MasterControl

MasterControl, Inc. · Founded 1993 · Salt Lake City, UT, USA

Validated EQMS used by the US FDA itself for document control, CAPA, training, and 21 CFR Part 11 records.

Opaque pricingG2 4.3 · Capterra 4.5 · 540+ reviews

Summary

MasterControl was founded in 1993 in Salt Lake City and built the regulated-life-sciences EQMS category. The Quality Excellence suite covers document control, training management, CAPA, change control, audit, supplier quality, and risk in one validated platform. The most-cited reference customer is the US Food and Drug Administration itself, which has used MasterControl for internal quality processes since 2009. MasterControl Manufacturing Excellence added an electronic device history record (eDHR) capability and a Manufacturing Execution System (MxP) to the same tenant in 2023-2024. Sumeru Equity Partners took a majority stake in 2020; the platform serves 1,000+ regulated-industry customers including a large medical-device installed base spanning class II and class III device manufacturers.

Strengths
  • US Food and Drug Administration uses MasterControl for internal document and quality processes; the strongest reference customer in regulated life sciences
  • Deep installed base in medical device manufacturing for 21 CFR Part 820 QMSR document control, training, and CAPA workflow
  • Manufacturing Excellence module added electronic device history records (eDHR) and MES capabilities in 2023-2024, extending coverage from quality into device shop-floor execution
  • Validation Excellence Tool (VxT) ships pre-built validation packages (IQ / OQ / PQ) that cut typical device validation cycles 30-50% per vendor benchmarks
  • 33-year operating history with regulated customers; consistent presence in Gartner Hype Cycle for life-sciences QMS
  • Strong audit-trail granularity at field-level for 21 CFR Part 11 § 11.10(e); reviewers consistently flag this for FDA Form 483 survivability
Weaknesses
  • Native 510(k) / De Novo / PMA submission templates are thinner than Greenlight Guru; submission-led buyers find the device-specific workflow less opinionated
  • Pricing is opaque and enterprise-tier; SoftwareAdvice and SelectHub triangulate $30K-$100K+ entry for mid-market and $200K+ for top-20 device manufacturers
  • Sumeru Equity Partners majority ownership since 2020 raises typical PE-owned renewal-uplift risk; ask for the cap in writing
  • G2 review patterns flag legacy UI elements that newer cloud entrants (Qualio, ComplianceQuest, Greenlight Guru) have moved past; mobile experience trails the SaaS-trust generation
  • Implementation is consultant-heavy; device deployments routinely require 6-12 months and 20-30% of first-year licence in services
  • Module-by-module pricing means Quality + Manufacturing + Validation Excellence can stack quickly toward $500K/yr for a top-20 device manufacturer deployment
Best for

Commercial-stage medical device manufacturers, contract manufacturers, and combination-product manufacturers that want a single validated EQMS owning document control, training, CAPA, change control, device history records, and supplier quality end-to-end with FDA-grade audit-trail credibility.

Worst for

Pre-Phase-1 virtual device startup that needs a cloud QMS in 60 days for under $50K; MasterControl is over-built and over-priced for that brief, where Qualio or Greenlight Guru Essentials fit better.

Key features

  • Document control with 21 CFR Part 11 electronic signatures
  • Training management with role-based curricula and read-and-understand tracking
  • CAPA workflow with root-cause analysis and effectiveness checks
  • Change control with cross-functional approval routing
  • Supplier quality management with ISO 13485 § 7.4 audit tracking
  • Audit management for internal, supplier, MDSAP, and regulatory inspections
  • Validation Excellence Tool (VxT) with pre-built IQ / OQ / PQ packages
  • Manufacturing Excellence with electronic device history records (eDHR)

Integrations

60+ native. Notable: SAP S/4HANA, Oracle E-Business Suite, Microsoft Entra ID, Okta, Salesforce, Veeva Vault (limited), Native REST API.

Target size

100 to 1,00,000 employees · US · Canada · EU · UK · AU · APAC · LATAM

#4

Veeva Vault QualityOne

Veeva Systems Inc. · Founded 2007 · Pleasanton, CA, USA

Cloud QMS on the Vault content platform for device manufacturers already running Vault RIM, Vault Clinical, or Vault Submissions.

Opaque pricingG2 4.2 · Capterra 4.3 · 180+ reviews

Summary

Veeva Systems was founded in 2007 by Peter Gassner and built the life-sciences cloud category around the Vault content platform. Vault QualityOne is the medical-device and consumer-products application of the Vault QMS data model; it shares the same data model and validated infrastructure as Vault Clinical Operations, Vault RIM, and Vault Submissions. Veeva customers in medical device and combination-product manufacturing use QualityOne as the QMS layer alongside Vault RIM for regulatory submissions and Vault Clinical for device-related clinical trials. The platform is multi-tenant SaaS with validated configuration delivered on the Veeva release cadence (three releases per year). Vault QualityOne coverage spans deviations, CAPA, change control, complaints, supplier quality, audit, and quality issue management for device manufacturers and IVD developers.

Strengths
  • Native interoperability with Vault RIM, Vault Submissions, and Vault Clinical on the same data model and validated infrastructure; natural pick for combination-product manufacturers running drug and device on Vault
  • Public-company ownership (NYSE: VEEV) and a 17-year operating history give procurement teams the stability story their CFO wants
  • Three-release-per-year cadence with validation packages delivered by Veeva; reduces customer validation burden vs single-tenant alternatives
  • Strong fit for device companies already running Vault RIM for FDA submissions or Vault Clinical for premarket trials
  • Native API and Vault Connections framework for clean data movement across Vault applications and external systems
  • Multi-tenant SaaS with validated configuration; Veeva owns the platform-level 21 CFR Part 11 audit trail
Weaknesses
  • Pricing is opaque; SelectHub and Vendr triangulate $100K-$500K+/yr for mid-market and top-20 device manufacturer deployments respectively
  • Multi-tenant SaaS with vendor-controlled validation timeline; device customers cannot opt out of the three-release-per-year cadence even when they would prefer it
  • Best return on investment requires the customer to already run other Vault applications; standalone Vault QualityOne shoppers typically find better value with Greenlight Guru or MasterControl
  • Native 510(k) / De Novo / PMA submission templates rely on the Vault RIM and Vault Submissions adjacencies rather than being native to QualityOne itself
  • Native batch-record (electronic device history record) story is thinner than MasterControl Manufacturing Excellence or Sparta TrackWise Digital for high-volume device manufacturers
  • Implementation typically requires Veeva certified partner involvement; partner costs commonly 25-40% of first-year licence for global device manufacturer deployments
Best for

Medical device and combination-product manufacturers already running two or more Veeva Vault applications (RIM, Submissions, Clinical) that want a QMS sharing the same validated data model and three-release-per-year cadence.

Worst for

Standalone QMS shoppers without an existing Vault footprint; the value proposition collapses without the Vault RIM and Submissions adjacencies, and the price tag remains enterprise-grade.

Key features

  • Deviation management with cross-site routing
  • CAPA workflow with effectiveness verification
  • Change control with multi-discipline approval
  • Complaints management aligned to FDA 21 CFR 803 MDR and EU MDR Article 87
  • Supplier quality with audit and qualification tracking
  • Audit management for internal, supplier, MDSAP, and regulatory inspections
  • Quality issue management with risk-based escalation
  • Vault Connections for cross-application data movement with Vault RIM and Vault Submissions

Integrations

40+ native. Notable: Veeva Vault RIM, Veeva Vault Submissions, Veeva Vault Clinical Operations, SAP S/4HANA (via Vault Connections), Microsoft Entra ID, Native Vault API.

Target size

200 to 1,00,000 employees · US · Canada · EU · UK · AU · APAC · LATAM

#5

ETQ Reliance

ETQ (Hexagon AB subsidiary) · Founded 1992 · Burlington, MA, USA

Configurable enterprise EQMS with 40+ pre-built compliance applications across medical device and life sciences.

Opaque pricingG2 4.4 · Capterra 4.4 · 220+ reviews

Summary

ETQ was founded in 1992 and acquired by Hexagon AB in January 2022 for approximately $750M. ETQ Reliance is a configurable enterprise QMS that ships 40+ pre-built compliance applications spanning document control, training, CAPA, audit, supplier quality, change control, complaint handling, and risk register. Medical device customers use Reliance NXG for site-by-site validated rollouts plus the integration depth that Hexagon's manufacturing intelligence portfolio brings via Smart Manufacturing. ETQ is a Gartner Magic Quadrant QMS Leader (2024 placement); review patterns flag configurability as both the strongest selling point and the steepest implementation cost.

Strengths
  • Gartner Magic Quadrant QMS Leader (2024 placement); strong analyst credibility for regulated device buyers running a parallel QMS bake-off
  • 40+ pre-built compliance applications including document control, training, CAPA, audit, supplier quality, change control, complaints, and risk register
  • Reliance NXG architecture supports site-by-site validated rollouts with delta-revalidation rather than full re-validation on platform updates
  • Hexagon ownership since January 2022 brings adjacent Manufacturing Intelligence, Asset Lifecycle Intelligence, and Smart Manufacturing portfolio depth
  • Configurable workflow and form designer means non-standard device processes (combination products, IVD-specific workflows, drug-device combinations) can be modelled without code
  • Multi-site supplier quality with audit-history aggregation; well-suited to global device manufacturers with 30+ supplier sites
Weaknesses
  • Pricing is opaque and enterprise-tier; Vendr and SelectHub triangulate $80K-$300K+ entry for mid-market and $250K-$700K+ for top-20 device manufacturers
  • Hexagon ownership is two-edged; the manufacturing-intelligence adjacency is real, but the corporate roadmap can re-prioritise the QMS line against bigger Hexagon bets
  • Configurability is a strength on day 365 and a tax on day 1; admin learning curve is steep and reviewers note time-to-first-validated-process
  • Implementation routinely 6-9 months with a Hexagon or partner systems integrator; total cost-to-go-live 25-40% of first-year licence
  • Native 510(k) / De Novo / PMA submission templates are thinner than Greenlight Guru; submission-led device buyers find the device-specific workflow less opinionated
  • Less natural fit for cloud-first emerging device startups; the configurability tax is unrecoverable at series-A scale
Best for

Large and global medical device manufacturers running site-by-site validated rollouts who need a configurable enterprise QMS, deep supplier quality across many manufacturing sites, and an integration story with Hexagon Manufacturing Intelligence or Smart Manufacturing.

Worst for

Emerging device startups under series C and pre-commercial IVD developers; the configurability tax and implementation effort do not survive the budget envelope.

Key features

  • Document control with 21 CFR Part 11 electronic signatures
  • Training management with role-based curricula
  • CAPA workflow with effectiveness verification
  • Change control with cross-functional routing
  • Supplier quality management with multi-site audit history
  • Audit management for internal, supplier, MDSAP, and regulatory
  • Complaint handling and adverse-event intake aligned to FDA 21 CFR 803
  • Risk register with configurable scoring

Integrations

75+ native. Notable: SAP S/4HANA, Oracle E-Business Suite, Microsoft Entra ID, Salesforce, Hexagon Smart Manufacturing, Honeywell Forge, Native REST API.

Target size

500 to 1,00,000 employees · US · Canada · EU · UK · AU · APAC · LATAM

#6

Sparta TrackWise Digital

Sparta Systems (Honeywell company) · Founded 1994 · Hamilton, NJ, USA

Cloud-native QMS that succeeds the legacy TrackWise installed at the largest medical device manufacturers.

Opaque pricingG2 4.2 · Capterra 4.3 · 110+ reviews

Summary

Sparta Systems was founded in 1994 and built TrackWise into a historical QMS incumbent across pharma and medical-device manufacturing; the legacy product is installed at 9 of the top 10 global pharmaceutical companies and many of the top medical-device manufacturers. Honeywell acquired Sparta in January 2021 for approximately $1.3B and folded the platform into Honeywell Forge. TrackWise Digital is the AWS-hosted cloud successor that ships native validation, configurable workflow, and AI-assisted deviation and CAPA triage; it is the migration target for legacy TrackWise customers and the new-deployment target for top-20 device manufacturers running cloud-first quality strategies. Pricing is opaque and enterprise-tier; reference customers include large pharma, biotech, and medical-device manufacturers.

Strengths
  • Legacy TrackWise is installed at many of the top medical-device manufacturers per Sparta references; deep top-manufacturer footprint
  • Cloud-native TrackWise Digital on AWS with native validation packages; cuts site-by-site validation effort 30-50% vs on-prem legacy TrackWise
  • Honeywell Forge adjacency since January 2021 brings Connected Plant, OT cybersecurity, and asset performance into the QMS conversation for top-20 device manufacturing
  • AI-assisted deviation and CAPA triage shipped in 2024-2025 releases; reviewers flag time-to-root-cause reductions of 30-40%
  • Strong fit for regulated device customers already running Honeywell Experion DCS or Honeywell Forge OT platform across manufacturing sites
  • Configurable workflow and form designer supports non-standard device processes (combination products, electromedical equipment, sterile devices)
Weaknesses
  • Pricing is opaque and enterprise-tier; SelectHub and Vendr triangulate $150K-$500K+/yr typical for mid-market device manufacturers and $500K-$1.5M+/yr for top-20 deployments
  • Honeywell ownership since January 2021 brings corporate-roadmap risk; QMS prioritisation can shift against bigger Honeywell bets in OT and aerospace
  • Migration from legacy on-prem TrackWise to TrackWise Digital is non-trivial; reviewers note 6-12 months and 30-40% of new licence in services
  • Implementation requires Honeywell or certified partner involvement; the consultant bench is smaller than MasterControl or ETQ
  • Native 510(k) / De Novo / PMA submission templates are not as opinionated as Greenlight Guru; device submission-led buyers see thinner workflow
  • Less natural fit for emerging device startups and mid-market IVD; pricing and platform DNA are top-20-manufacturer-shaped
Best for

Top-20 global device manufacturers, large combination-product manufacturers, and contract manufacturers running cloud-first quality strategies, especially those migrating from legacy on-prem TrackWise or already running Honeywell Forge / Experion across manufacturing sites.

Worst for

Emerging device startups under series C and small specialty IVD developers; the platform is priced and architected for top-20-manufacturer scale, not startup budgets.

Key features

  • Deviation management with cross-site routing
  • CAPA workflow with AI-assisted root-cause triage
  • Change control with multi-discipline approval
  • Audit management for internal, supplier, MDSAP, and regulatory
  • Supplier quality with audit-history aggregation
  • Complaints management aligned to FDA 21 CFR 803 MDR
  • Risk-based deviation triage with AI
  • Honeywell Forge adjacency for OT and Connected Plant

Integrations

50+ native. Notable: Honeywell Forge, Honeywell Experion DCS, SAP S/4HANA, Oracle E-Business Suite, Microsoft Entra ID, Veeva Vault (limited), Native REST API.

Target size

1,000 to 2,00,000 employees · US · Canada · EU · UK · AU · APAC · LATAM

#7

ComplianceQuest

ComplianceQuest, Inc. · Founded 2014 · Tampa, FL, USA

Salesforce-native EQMS plus EHS and PLM with 100% cloud architecture for regulated medical device.

Opaque pricingG2 4.5 · Capterra 4.6 · 240+ reviews

Summary

ComplianceQuest was founded in 2014 and built a Salesforce-native EQMS for regulated industries with pharma, biotech, MedTech, and food and beverage as primary verticals. The product ships on the Salesforce platform with native validation packages and inherits Salesforce SSO, mobile, AppExchange, and Einstein AI. Coverage spans document control, training, CAPA, audit, supplier quality, change control, complaint handling, EHS, and PLM in one tenant. Insight Partners took a minority position in 2022. ComplianceQuest is a Gartner Magic Quadrant QMS Visionary; medical device customers use the platform when they already run Salesforce Sales Cloud, Service Cloud, or Marketing Cloud and want to consolidate device quality on the same data platform.

Strengths
  • Salesforce-native architecture means inherited Salesforce SSO, mobile, AppExchange, and Einstein AI features without separate integration work
  • 100% cloud-native with multi-tenant SaaS and validated configuration; faster time-to-validated-go-live than on-prem QMS competitors
  • Coverage spans EQMS + EHS + PLM in one tenant, useful for device manufacturers combining quality + safety + product-development briefs
  • Gartner Magic Quadrant QMS Visionary placement; strong analyst credibility for parallel bake-offs against MasterControl and ETQ
  • Independent ownership with Insight Partners minority investment 2022; no full-PE renewal-pressure dynamic
  • Strong fit for device manufacturers already running Salesforce Sales Cloud, Service Cloud, or Marketing Cloud who want to consolidate quality on the same data platform
Weaknesses
  • Pricing is opaque; Vendr and SelectHub triangulate $60K-$200K+/yr typical for mid-market device manufacturers; per-user Salesforce licensing layers on top
  • Salesforce dependency is two-edged; non-Salesforce device manufacturers absorb a platform tax, and a future Salesforce price-uplift cascades to ComplianceQuest customers
  • Native 510(k) / De Novo / PMA submission templates are thinner than Greenlight Guru; device submission-led buyers see less opinionated workflow
  • Smaller G2 / Capterra review base than MasterControl, Veeva Vault, ETQ, or Greenlight Guru; harder to validate via peer-review patterns
  • Native CAPA and deviation depth is competitive at mid-market scale but trails MasterControl and ETQ at top-20-device-manufacturer site-by-site validated rollout scale
  • Implementation typically requires ComplianceQuest or certified partner involvement; the consultant bench is smaller than MasterControl or Veeva
Best for

Mid-market and growing medical device manufacturers, IVD developers, and combination-product companies already running Salesforce Sales Cloud, Service Cloud, or Marketing Cloud who want a cloud-native EQMS that shares the same data platform.

Worst for

Device manufacturers running on SAP S/4HANA or Oracle E-Business Suite without a Salesforce footprint; the Salesforce platform tax does not amortise without an existing Salesforce contract.

Key features

  • Salesforce-native data model
  • Document control with 21 CFR Part 11 electronic signatures
  • Training management with read-and-understand tracking
  • CAPA workflow with effectiveness verification
  • Audit management for internal, supplier, MDSAP, and regulatory
  • Supplier quality management with ISO 13485 § 7.4 audit tracking
  • Complaint handling aligned to FDA 21 CFR 803 MDR and EU MDR Article 87
  • EHS and PLM modules on the same data model
  • Einstein AI for evidence summarisation and CAPA root-cause assistance

Integrations

80+ native. Notable: Salesforce AppExchange ecosystem, Microsoft Entra ID, Microsoft 365, SAP (via Salesforce connectors), Workday, DocuSign, Native REST API.

Target size

100 to 25,000 employees · US · Canada · EU · UK · AU · APAC · LATAM

#8

Qualio

Qualio, Inc. · Founded 2012 · San Francisco, CA, USA

Cloud-native QMS with published pricing targeted at emerging device startups and contract manufacturers.

Partial pricingG2 4.6 · Capterra 4.7 · 400+ reviews

Summary

Qualio was founded in 2012 by Robert Fenton and Stephen Bligh and built a cloud-native QMS for emerging life-sciences companies. Sapphire Ventures and Series B Capital led a $50M Series B in 2021. The product targets virtual device startups, contract manufacturers, IVD developers, and biotech under 250 staff with a 60-90-day time-to-validated-deployment and published entry pricing ($24K Essentials, $50K Plus). Qualio is a G2 Leader in the SMB Quality Management QMS category with 380+ reviews at 4.6/5. Coverage spans document control, training, CAPA, audit, supplier quality, and risk management with ISO 13485 alignment and 21 CFR Part 820 QMSR support.

Strengths
  • Published entry pricing ($24K Essentials, $50K Plus); the most transparent QMS pricing in this ranking after Greenlight Guru
  • 60-90-day time-to-validated-deployment for emerging device startups and contract manufacturers; fastest first-510(k)-submission readiness in the category
  • Cloud-native multi-tenant SaaS with validated configuration; vendor handles platform-level 21 CFR Part 11 audit trail
  • G2 Leader for SMB Quality Management QMS with 380+ reviews at 4.6/5
  • Independent ownership with no full-PE renewal-pressure dynamic
  • Strong fit for virtual device startups, IVD developers, and contract manufacturers under 250 staff who want a validated QMS in under 90 days
Weaknesses
  • Targeted at SMB scale; the platform is not architected for top-20 device manufacturer site-by-site validated rollouts across 30+ sites
  • Native 510(k) / De Novo / PMA submission templates are thinner than Greenlight Guru; submission-led buyers find the device-specific workflow less opinionated
  • Native batch-record (electronic device history record) depth is limited; high-volume device manufacturing buyers find MasterControl Manufacturing Excellence or Sparta TrackWise Digital a better fit
  • Smaller integration count than MasterControl, Veeva Vault, ETQ, or ComplianceQuest; ERP / MES adjacencies require custom work
  • Limited multi-site rollup; not the right pick for global device manufacturers with 10+ manufacturing sites
  • Less natural fit for combination-product manufacturers running drug and device sides; pure-device DNA shows in the workflow
Best for

Emerging medical device startups, IVD developers, contract manufacturers, and clinical-stage device companies under 250 staff that need a validated cloud QMS in under 90 days with published pricing.

Worst for

Top-20 device manufacturers running site-by-site validated rollouts across 30+ sites; the platform is SMB-shaped and the multi-site rollup is limited.

Key features

  • Document control with 21 CFR Part 11 electronic signatures
  • Training management with read-and-understand tracking
  • CAPA workflow with effectiveness verification
  • Audit management for internal, supplier, and regulatory
  • Supplier quality with ISO 13485 § 7.4 audit tracking
  • Risk register with configurable scoring
  • ISO 13485:2016 clause-level workflow
  • 21 CFR Part 820 QMSR pre-built control library

Integrations

25+ native. Notable: Microsoft Entra ID, Okta, Google Workspace, Slack, Jira, DocuSign, Native REST API.

Target size

10 to 500 employees · US · Canada · EU · UK · AU

#9

Pilgrim Quality Solutions

Pilgrim Quality Solutions (an IQVIA business) · Founded 1993 · Tampa, FL, USA

SmartSolve EQMS plus iComplyGRC for mid-market medical device with 30-year regulated life-sciences pedigree.

Opaque pricingG2 4.1 · Capterra 4.3 · 130+ reviews

Summary

Pilgrim Quality Solutions was founded in 1993 and acquired by IQVIA (formerly Quintiles) in 2015. The flagship products are SmartSolve EQMS for document control, training, CAPA, audit, supplier quality, change control, and complaint handling, plus iComplyGRC for compliance and supplier risk. Pilgrim serves 800+ regulated-life-sciences customers across pharma, biotech, MedTech, and clinical research with a 30-year operating history. IQVIA ownership unlocks adjacent clinical, commercial, and technology services that medical device manufacturers running combined clinical-evaluation and post-market briefs find useful.

Strengths
  • 30-year operating history with regulated life-sciences customers; 800+ customer reference base spans pharma, biotech, MedTech, and clinical research
  • IQVIA ownership since 2015 unlocks adjacent clinical, commercial, and technology services for device manufacturers running combined clinical-evaluation and post-market briefs
  • SmartSolve EQMS covers document control, training, CAPA, audit, supplier quality, change control, and complaint handling in one tenant
  • iComplyGRC adds compliance management and supplier risk to the EQMS layer
  • Strong fit for mid-market device manufacturers and IVD developers that want an IQVIA-aligned vendor relationship
  • Consistent presence in regulated-life-sciences QMS analyst reports
Weaknesses
  • Pricing is opaque; SelectHub and Vendr triangulate $50K-$200K+/yr typical for mid-market device manufacturers
  • IQVIA corporate roadmap can re-prioritise the Pilgrim line against bigger IQVIA bets in clinical and commercial services
  • Native 510(k) / De Novo / PMA submission templates are thinner than Greenlight Guru; device submission-led buyers see less opinionated workflow
  • Smaller G2 / Capterra review base than MasterControl, Veeva Vault, or Greenlight Guru; harder to validate via peer-review patterns
  • Implementation routinely requires Pilgrim or IQVIA partner involvement; the consultant bench is smaller than MasterControl or ETQ
  • UI generations behind newer cloud entrants (ComplianceQuest, Qualio, Greenlight Guru); reviewers consistently flag UX as a weakness
Best for

Mid-market medical device manufacturers and IVD developers that want an IQVIA-aligned vendor relationship and a 30-year regulated-life-sciences pedigree in their QMS supplier.

Worst for

Cloud-first device startups expecting a modern SaaS user experience; the platform shows its operational-heritage and the UX trails newer entrants.

Key features

  • Document control with 21 CFR Part 11 electronic signatures
  • Training management with read-and-understand tracking
  • CAPA workflow with effectiveness verification
  • Audit management for internal, supplier, MDSAP, and regulatory
  • Supplier quality with ISO 13485 § 7.4 audit tracking
  • Change control with cross-functional approval routing
  • Complaint handling aligned to FDA 21 CFR 803 MDR
  • iComplyGRC compliance management and supplier risk

Integrations

40+ native. Notable: SAP S/4HANA, Oracle E-Business Suite, Microsoft Entra ID, Salesforce, IQVIA clinical platforms, Native REST API.

Target size

100 to 25,000 employees · US · Canada · EU · UK · AU · APAC

#10

AssurX

AssurX, Inc. · Founded 1993 · Morgan Hill, CA, USA

Configurable eQMS with 30-year heritage in regulated electronics and medical devices.

Opaque pricingG2 4.2 · Capterra 4.4 · 110+ reviews

Summary

AssurX was founded in 1993 and built a configurable eQMS with deep roots in regulated electronics, medical devices, and life sciences. The platform covers CAPA, change control, audit, complaint handling, document control, training, supplier quality, risk management, and submission management for 510(k), PMA, EU MDR, and IVDR. AssurX serves a mid-market and enterprise customer base including combination-product manufacturers and electromedical equipment makers. The platform is independent and privately held with a 30-year operating history; reviewers consistently flag configurability and customer support as strengths and pricing opacity as a weakness.

Strengths
  • 30-year operating history in regulated electronics and medical devices; deep customer reference base in combination-products and electromedical equipment
  • Configurable workflow and form designer means non-standard device processes (combination products, electromedical equipment, sterile devices) can be modelled without code
  • Native 510(k) / PMA / EU MDR / IVDR submission management module
  • AssurX UDI module for 21 CFR Part 830 and EUDAMED UDI database submission
  • Strong CAPA, change control, and complaint handling workflow
  • Independent ownership with no PE renewal-pressure dynamic
Weaknesses
  • Pricing is opaque; SelectHub and Vendr triangulate $60K-$250K+/yr typical for mid-market device manufacturers
  • Smaller G2 / Capterra review base than MasterControl, Veeva Vault, Greenlight Guru, or Qualio; harder to validate via peer-review patterns
  • Implementation routinely requires AssurX or partner involvement; the consultant bench is smaller than MasterControl or ETQ
  • UI generations behind newer cloud entrants (ComplianceQuest, Qualio, Greenlight Guru); reviewers flag UX as needing modernisation
  • Configurability is a strength on day 365 and a tax on day 1; admin learning curve is steep
  • Less natural fit for cloud-first emerging device startups; the configurability tax is unrecoverable at series-A scale
Best for

Combination-product manufacturers, electromedical equipment makers, and mid-market device manufacturers that want a configurable eQMS with native 510(k) / PMA / EU MDR / IVDR submission management and UDI module support.

Worst for

Cloud-first emerging device startups under series C expecting a modern SaaS user experience with published pricing; AssurX is enterprise-shaped and the UX trails newer entrants.

Key features

  • CAPA workflow with effectiveness verification
  • Change control with cross-functional approval routing
  • Complaint handling aligned to FDA 21 CFR 803 MDR
  • Audit management for internal, supplier, MDSAP, and regulatory
  • Document control with 21 CFR Part 11 electronic signatures
  • Training management with role-based curricula
  • Supplier quality with ISO 13485 § 7.4 audit tracking
  • 510(k) / PMA / EU MDR / IVDR submission management
  • AssurX UDI module for 21 CFR Part 830 and EUDAMED

Integrations

35+ native. Notable: SAP, Oracle, Microsoft Entra ID, Salesforce, DocuSign, Native REST API.

Target size

200 to 25,000 employees · US · Canada · EU · UK · AU

Step by step

Buying guide

Walk these steps in order. The shortlist falls out of step 1, the negotiation moves come together in step 6, and step 8 closes the deal.

  1. 1

    Name the primary buyer profile in one sentence

    Medical device compliance shortlists fall out of four buyer profiles. Profile A: a commercial-stage device manufacturer running 21 CFR Part 820 QMSR + ISO 13485 + EU MDR at 1 to 30+ sites with a single validated EQMS. Profile B: a pre-revenue or clinical-stage device startup preparing for first 510(k), De Novo, or PMA submission. Profile C: a combination-product manufacturer running 21 CFR Part 820 design controls alongside 21 CFR Part 211 GMP. Profile D: an in vitro diagnostic developer running IVDR 2017/746 technical-file workflow alongside FDA 510(k) or De Novo. Write down which profile you fit before reading product cards; the ranking changes by profile.

  2. 2

    Map your frameworks before you shortlist tools

    Write down every regulatory framework you must demonstrate compliance against in the next 24 months. Typical commercial-stage device manufacturer stack: FDA 21 CFR Part 820 QMSR (effective Feb 2 2026), ISO 13485:2016, ISO 14971:2019, IEC 62304 if SaMD, EU MDR 2017/745, UDI (21 CFR Part 830 + EUDAMED), 21 CFR Part 11, MDSAP. Typical IVD developer stack: the above plus EU IVDR 2017/746. Typical combination-product stack: the above plus 21 CFR Part 211 GMP, ICH Q9 / Q10, GAMP 5. Platforms with library depth for your specific stack win; platforms that hand-map are taxed.

  3. 3

    Filter by employee count and budget band first

    Under 50 staff with a sub-$50K budget filters in only Qualio Essentials and the lower Greenlight Guru Essentials tier. 50 to 250 staff with $50K-$100K opens Qualio Plus, Greenlight Guru Pro, ComplianceQuest mid-market, AssurX mid-market, and Pilgrim. 250 to 2,500 staff with $100K-$300K opens MasterControl, ETQ Reliance, Veeva Vault QualityOne clinical-stage, RiskWatch Professional / Enterprise, and AssurX Enterprise. 2,500+ staff with $300K+ opens all ten with Sparta TrackWise Digital, Veeva Vault QualityOne Commercial, MasterControl Global, and ETQ Reliance Global doing most of the work.

  4. 4

    Validate FDA QMSR coverage at the sub-section level given the Feb 2 2026 effective date

    Every vendor will tell you they cover the FDA QMSR. Ask each one to show you their pre-built control library mapped to Subpart B Design Controls § 820.30, Subpart C Document Controls § 820.40, Subpart E Purchasing Controls § 820.50, Subpart G Production and Process Controls § 820.70, Subpart H Acceptance Activities § 820.80, Subpart I Nonconforming Product § 820.90, Subpart J CAPA § 820.100, Subpart M Records § 820.180, and Subpart O Servicing § 820.200. Ask which sub-sections are pre-mapped versus which require manual configuration. Ask whether the vendor will share their most-recent QMSR readiness statement and any FDA Form 483 inspection observations involving the platform. A 30-minute exercise here cuts a 6-month implementation surprise.

  5. 5

    Pressure-test EU MDR + IVDR readiness given Regulation 2024/1860 transition deadlines

    EU MDR 2017/745 and IVDR 2017/746 transition deadlines were amended by Implementing Regulation 2024/1860 to December 31 2027 / 2028 / 2029 / 2030 by risk class. Any QMS or compliance platform that does not currently maintain a live EU MDR and IVDR technical-file workflow with these dates baked in is not credible for an EU-market device manufacturer. Ask each vendor to publish their MDR / IVDR readiness statement, their pre-built technical-file template against Annex II and Annex III of MDR (and equivalent IVDR Annexes), and their position on EUDAMED UDI submission.

  6. 6

    Pull the G2 and Capterra review patterns from the last 12 months

    Read 20+ verified reviews per shortlisted vendor from the last 12 months. Look for patterns, not single outliers. Patterns we observe in medical device specifically: 'FDA reference customer earns trust on day one' (MasterControl); 'MedTech-first DNA shows in every workflow' (Greenlight Guru); 'value collapses without other Vault apps' (Veeva Vault QualityOne); 'configurability is a tax on day 1 and a moat on day 365' (ETQ Reliance, AssurX); 'fastest validated-deployment we have seen' (Qualio); 'Salesforce DNA is the deciding factor' (ComplianceQuest); 'overkill for our size' (Sparta TrackWise Digital at sub-1,000 staff). Confirm or rebut the patterns with reference calls.

  7. 7

    Insist on a 30-day pilot with your real validated data, not a demo

    Demos are choreographed; pilots are not. Ask each finalist for a 30-day pilot with: three control framework imports (FDA QMSR + ISO 13485 + EU MDR), one design history file import, one supplier qualification record, one CAPA workflow exercise, one change-control approval routing test, and one inspector-ready export. The platform that handles your real validated data without three weeks of professional services is the one that will survive an FDA Form 483, an EU Notified Body audit, or an MDSAP inspection. If a vendor refuses a working pilot, escalate or walk.

  8. 8

    Ask for the renewal-escalator cap and the data-residency clause in writing

    Renewal-pricing pressure is the silent budget killer in medical device compliance. PE-owned vendors (MasterControl / Sumeru, ETQ / Hexagon, Sparta / Honeywell, Greenlight Guru / JMI Equity) routinely push 8-15% uplifts. Ask for the renewal-escalator cap in the master agreement and walk if the vendor refuses. Separately, ask where your validated QMS records live, who can access them, and what happens if you terminate. RiskWatch and MasterControl both support single-tenant deployment with customer-owned data residency; Veeva Vault QualityOne, ComplianceQuest, Qualio, and TrackWise Digital are multi-tenant SaaS where the BAA-equivalent quality agreement is the data-residency control.

  9. 9

    Run the decision matrix on this page with your own weights

    The default methodology weights on this page (20% Ease, 20% Features, 20% Value, 15% Support, 15% Scalability, 10% Integrations) reflect a generic mid-market medical device buyer. Top-20 device manufacturers should push Scalability and Integrations up; emerging device startups should push Ease of Use and Value up; combination-product manufacturers should push Features up (design controls plus GMP); IVD developers should push Features up (IVDR-specific workflow). Use the decision-matrix slider on this page to re-rank with your weights before booking demos.

Frequently asked

Buyer questions, answered

The eight questions our pre-sales team hears the most often when buyers compare this category.

What is medical device compliance management software?
Medical device compliance management software is a category of platforms that help device manufacturers, in vitro diagnostic (IVD) developers, and combination-product manufacturers manage the FDA Quality Management System Regulation (21 CFR Part 820 QMSR, effective February 2 2026 and harmonised with ISO 13485:2016), EU Medical Device Regulation 2017/745, EU IVDR 2017/746, ISO 14971 risk management, IEC 62304 software-of-medical-device lifecycle, UDI assignment under 21 CFR Part 830 and EUDAMED, 510(k) / De Novo / PMA submission workflow, MDSAP audit readiness, and post-market surveillance plus vigilance reporting. The ten platforms in this ranking each solve part of that brief; none solves all of it equally well, which is why the right pick depends on whether the buyer is a commercial-stage manufacturer, an emerging device startup, a combination-product manufacturer, or an IVD developer.
What changes with the FDA QMSR effective February 2 2026 and how does it affect platform selection?
The FDA published the Quality Management System Regulation (QMSR) final rule under 89 FR 7496 on February 2 2024, with an effective date of February 2 2026. The QMSR replaces the long-standing 21 CFR Part 820 Quality System Regulation (QSR) and incorporates ISO 13485:2016 by reference, harmonising the FDA quality-system requirements with the international standard already used by EU MDR, Health Canada, ANVISA, TGA, and PMDA. The practical consequence for platform selection: vendors that already shipped ISO 13485:2016 clause-level workflow are well-positioned; vendors that built around the legacy QSR sub-section structure need to update their pre-built control libraries to the QMSR clause structure. Ask each vendor to show their published QMSR readiness statement, their pre-built QMSR control library, and their mapping between the legacy QSR sub-sections and the new QMSR clauses before signing.
Which platform is the best fit for an emerging device startup preparing for a first 510(k)?
Greenlight Guru and Qualio are the closest fits for emerging device startups under series C preparing for a first 510(k). Greenlight Guru is MedTech-first by design with native 510(k) submission templates aligned to FDA eSTAR and 1,000+ verified reviews from device-specific reviewers; Essentials pricing is reported at $25K-$40K/yr and Pro at $60K-$120K/yr. Qualio is the lower-cost alternative with published Essentials $24K and Plus $50K pricing and a 60-90-day time-to-validated-deployment, though 510(k) submission workflow is thinner than Greenlight Guru. Larger device startups and commercial-stage manufacturers typically outgrow Qualio within 18-24 months and migrate to Greenlight Guru, MasterControl, or Veeva Vault QualityOne.
How much should a medical device manufacturer budget for compliance management software in 2026?
Entry pricing ranges from approximately $24K/yr (Qualio Essentials) to $1.5M+/yr (Sparta TrackWise Digital top-20-manufacturer deployments). An emerging device startup preparing for first 510(k) typically spends $25K-$60K/yr on licence plus 10-20% in implementation services. A mid-market commercial-stage device manufacturer spending across QMS + supplier quality + audit routinely spends $80K-$250K/yr on a single platform plus 20-30% in implementation. A top-20 global device manufacturer running site-by-site validated rollouts across 30+ manufacturing sites routinely spends $500K-$2M/yr across multiple modules from one or two vendors. Always model 3-year total cost of ownership and ask for the renewal-escalator cap in writing.
How do the EU MDR and IVDR transition deadlines affect platform selection?
The European Commission Implementing Regulation 2024/1860 amended the legacy-device transition deadlines under EU MDR 2017/745 to December 31 2027 for risk class III, December 31 2028 for risk class IIb, and December 31 2029 for class IIa / Im / Is. EU IVDR 2017/746 transition deadlines were extended on the same Regulation 2024/1860 schedule with longer runway for lower-risk IVDs (December 31 2027 / 2028 / 2029 / 2030 by IVD class). The practical consequence for platform selection: any QMS or compliance platform that does not currently maintain a live EU MDR and IVDR technical-file workflow with these dates baked in is not credible for an EU-market device manufacturer. Ask each vendor to show their published MDR / IVDR readiness statement and their pre-built technical-file template against Annex II and Annex III of MDR and the equivalent IVDR Annexes before signing.
Which platforms handle UDI assignment to FDA GUDID and EUDAMED in one workflow?
Unique Device Identification (UDI) under 21 CFR Part 830 requires device labellers to assign UDIs and submit them to the FDA Global Unique Device Identification Database (GUDID). EU MDR Article 27 and EU IVDR Article 24 require equivalent UDI submission to EUDAMED. AssurX ships a native UDI module covering both GUDID and EUDAMED. Greenlight Guru and MasterControl ship UDI workflow as part of their device-specific eQMS suites. Veeva Vault QualityOne handles UDI through the Vault RIM adjacency. RiskWatch ships UDI as a framework library that captures the policy and supplier-attestation layer rather than a GUDID / EUDAMED submission engine. For a device manufacturer with high UDI volume, the right approach is often a dedicated UDI submission tool (Reed Tech, IQVIA, MediTech, IDENTI Medical) paired with the QMS for the policy and audit-trail layer.
Which platforms support MDSAP audit readiness across the five participating regulators?
The Medical Device Single Audit Program (MDSAP) lets device manufacturers undergo a single audit to satisfy regulators in the US (FDA), Canada (Health Canada), Brazil (ANVISA), Australia (TGA), and Japan (MHLW / PMDA). Health Canada requires MDSAP for any device manufacturer selling into Canada. MasterControl, Greenlight Guru, Veeva Vault QualityOne, ETQ Reliance, Sparta TrackWise Digital, ComplianceQuest, Pilgrim, AssurX, and Qualio all ship audit-management modules suitable for MDSAP audit preparation; depth varies by vendor. RiskWatch supports MDSAP at the framework-library and audit-evidence layer. Ask each vendor to share recent MDSAP audit observations involving the platform and their published MDSAP readiness statement before signing.
Does RiskWatch accept any money from the other vendors on this page?
No. RiskWatch accepts no affiliate fees, sponsorship money, or paid placements on this page. RiskWatch is also on the page, at #1. Readers should weigh the publishing relationship against the published evidence on this page.
Definitions

Glossary

Definitions for the acronyms and jargon used on this page. Useful for sharing with non-specialist stakeholders on the buying committee.

FDA QMSR (21 CFR Part 820)
US Food and Drug Administration Quality Management System Regulation under 21 CFR Part 820, effective February 2 2026 per 89 FR 7496. Replaces the long-standing 21 CFR Part 820 Quality System Regulation (QSR) and incorporates ISO 13485:2016 by reference. Covers design controls (§ 820.30), document controls (§ 820.40), purchasing controls (§ 820.50), production and process controls (§ 820.70), acceptance activities (§ 820.80), nonconforming product (§ 820.90), CAPA (§ 820.100), records (§ 820.180), and servicing (§ 820.200).
EU MDR 2017/745
European Union Medical Device Regulation 2017/745, governing the conformity assessment and post-market surveillance of medical devices placed on the EU market. Implementing Regulation 2024/1860 amended the legacy-device transition deadlines to December 31 2027 for class III, December 31 2028 for class IIb, and December 31 2029 for class IIa / Im / Is. Replaces the 1990s Medical Device Directive (MDD).
EU IVDR 2017/746
European Union In Vitro Diagnostic Regulation 2017/746, governing the conformity assessment of in vitro diagnostic medical devices. Implementing Regulation 2024/1860 extended legacy-device transition deadlines to December 31 2027 / 2028 / 2029 / 2030 by IVD risk class. Replaces the 1990s In Vitro Diagnostic Directive (IVDD).
ISO 13485:2016
International standard for medical-device quality management systems. Now incorporated by reference into the FDA QMSR effective February 2 2026, harmonising US, EU, Canada, Brazil, Australia, and Japan quality-system requirements around one international standard. Already required for CE marking under EU MDR and IVDR.
ISO 14971:2019
International standard for the application of risk management to medical devices. Defines the risk-management file structure, hazard analysis, risk evaluation, risk control, and post-production information feedback loop. Every device QMS in this ranking ships ISO 14971 workflow at varying depth.
IEC 62304
International standard for medical-device software life cycle processes. Covers software classification (Class A / B / C), software development planning, requirements analysis, architectural design, detailed design, unit implementation, integration testing, system testing, and release. Required reference for any software-of-medical-device (SaMD) submission.
UDI (Unique Device Identification)
Device-identification system required by FDA under 21 CFR Part 830 with submission to the Global Unique Device Identification Database (GUDID), and by EU MDR Article 27 / IVDR Article 24 with submission to EUDAMED. Every commercial medical device in the US and EU must carry a UDI and have its UDI record live in the regulatory database.
Final word

So which one should a medical device buyer pick?

If you read this page top to bottom and one platform stood out for your buyer profile (commercial-stage device manufacturer, emerging device startup, combination-product manufacturer, or in vitro diagnostic developer), that is your answer. The methodology is on this page so a quality director, a regulatory affairs lead, or a product development manager can disagree with the rank and arrive at a different first pick honestly. The position reflects our weights and the public evidence as of 2026-05-15.

Whatever you shortlist, insist on three contract terms before you sign: a 30-day working pilot with your real design history file and a real CAPA workflow (not a choreographed demo), a renewal-escalator cap written into the master subscription agreement, and a documented exit clause covering data-export format, retention, and price. The medical device buyers we see lose three-year deals lose them on those three terms, not on feature coverage.

If you would like the RiskWatch demo specifically tuned to FDA QMSR, ISO 13485, ISO 14971, IEC 62304, EU MDR, and IVDR in one tenant, request it at riskwatch.com/request-a-demo. If you would like a no-strings second-opinion on one of the other nine, email sales@riskwatch.com with the vendor name in the subject line and we will share what we know.

Request a Demo